SURTECO SE's AGM Approvals and Financial Overview

SURTECO GROUP SE's Annual General Meeting witnessed strong approval for all agenda items, with Jan Oberbeck being re-elected to the Supervisory Board. Despite challenging market conditions and weak demand, the company reported a decline in sales for 2025, dropping to €821.2 million from €856.6 million the previous year. Key contributing factors included the termination of the impregnation business and adverse currency effects, leading to a 2% decrease in organic sales.

Adjusted EBITDA fell to €80.2 million from €95.3 million. However, the company showed a positive start in 2026, achieving a consolidated profit of €1.3 million in Q1 after a prior-year loss. The firm projects 2026 sales between €780 million and €830 million with adjusted EBITDA between €70 and €90 million. No dividend proposal was made due to offsetting the 2025 net loss against retained earnings.